MedTrace Logo

Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies

NCT07046949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-12-16

No results posted yet for this study

Summary

The main goal of this randomised double-blinded controlled trial is to assess whether adding anterior quadratus lumborum block preoperatively can reduce intraoperative and postoperative opioid consumption, reduce pain after abdominal hysterectomy and improve quality of recovery after anesthesia. The study hypothesis is that anterior QL block bilaterally before the start of a surgery has no impact on perioperative pain relief, can't reduce the need in opioids and will not improve quality of recovery after anesthesia.

All patients will undergo general anesthesia with tracheal intubation and mechanical ventilation. Patients will be randomized into two groups. In addition to general anesthesia and multimodal analgesia with parenteral medication II (QL) group will receive also anterior quadratus lumborum block as a regional component.

Conditions

  • Uterine Bleeding
  • Uterine Neoplasms
  • Uterine Diseases
  • Uterine Fibroids

Interventions

PROCEDURE

ANTERİOR QUADRATUS LUMBORUM BLOCK

Ultrasound-guided anterior QL block performed preoperatively

DRUG

Parenteral administration of analgesics

Intravenous opioids or NSAIDs used perioperatively.

PROCEDURE

General Anesthesia (GA)

Standard general anesthesia per continious 1% propofol infusion and propofol bolus administration, atracurium and fentanyl administration.

Sponsors & Collaborators

  • Danylo Halytsky Lviv National Medical University

    collaborator OTHER

  • Yuri Semenyuk Rivne Regional Clinical Hospital

    lead OTHER

Principal Investigators

  • Olha Filyk, Professor · Danylo Halytsky Lviv National Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-07
Primary Completion
2025-12-08
Completion
2025-12-11

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07046949 on ClinicalTrials.gov